Literature DB >> 8444484

Actinomyces israelii in the female genital tract: a review.

D T Evans1.   

Abstract

Entities:  

Keywords:  Adnexitis; Antibiotics; Bacterial And Fungal Diseases--prevention and control; Biology; Contraception; Contraceptive Methods--complications; Diseases; Drugs; Examinations And Diagnoses; Family Planning; Infections; Iud--complications; Laboratory Examinations And Diagnoses; Literature Review; Pelvic Inflammatory Disease; Reproductive Tract Infections; Risk Factors; Screening; Treatment

Mesh：

Year:  1993        PMID： 8444484      PMCID： PMC1195012          DOI： 10.1136/sti.69.1.54

Source DB:  PubMed          Journal:  Genitourin Med        ISSN： 0266-4348


× No keyword cloud information.
  22 in total

1.  Actinomycosis of the female pelvic organs with involvement of the endometrium.

Authors:  J MACCARTHY
Journal:  J Pathol Bacteriol       Date:  1955 Jan-Apr

2.  The clinical significance of Actinomyces colonization as seen in cervical smears.

Authors:  H Dybdahl; J Hastrup; U Baandrup
Journal:  Acta Cytol       Date:  1991 Jan-Feb       Impact factor: 2.319

3.  Bilateral female pelvic actinomycosis.

Authors:  L K Hansen
Journal:  Acta Obstet Gynecol Scand       Date:  1989       Impact factor: 3.636

4.  Actinomycetes and the IUD: an update.

Authors:  P K Gupta; Y S Erozan; J K Frost
Journal:  Acta Cytol       Date:  1978 Sep-Oct       Impact factor: 2.319

5.  Actinomyces-like organisms in cervical smears from women using intrauterine contraceptive devices.

Authors:  H L Duguid; D Parratt; R Traynor
Journal:  Br Med J       Date:  1980-08-23

6.  Comparison between plaque inhibiting effect of chlorhexidine and aqueous solutions of copper- and silver-ions.

Authors:  S M Wåler; G Rölla
Journal:  Scand J Dent Res       Date:  1982-04

7.  Pelvic actinomycosis and the intrauterine contraceptive device. A cyto-histomorphologic study.

Authors:  R D Luff; P K Gupta; M R Spence; J K Frost
Journal:  Am J Clin Pathol       Date:  1978-06       Impact factor: 2.493

8.  Intrauterine devices and pelvic inflammatory disease: an international perspective.

Authors:  T M Farley; M J Rosenberg; P J Rowe; J H Chen; O Meirik
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

9.  Genital actinomycosis and intrauterine contraceptive devices. Cytopathologic diagnosis and clinical significance.

Authors:  B S Bhagavan; P K Gupta
Journal:  Hum Pathol       Date:  1978-09       Impact factor: 3.466

10.  Clinical evaluation of precipitin tests for genital actinomycosis.

Authors:  E Persson; K Holmberg
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948
View more
  6 in total

1.  Ultrasound-guided transvaginal aspiration in the management of actinomyces pelvic abscess.

Authors:  E Y Anteby; G Rahav; J Hanoch; S Shimonovitz; S Yagel; N Laufer
Journal:  Infect Dis Obstet Gynecol       Date:  1996

2.  Diagnostic dilemma posed by severe pelvic actinomycosis associated with prolonged use of copper intrauterine contraceptive device.

Authors:  Subhayu Bandyopadhyay; Sanjay Sinha; Patrick Fan Wui Chien; Dawn Fleming
Journal:  Clin Pract       Date:  2011-11-25

3.  Actinomyces-like organisms in cervical smears: the association with intrauterine device and pelvic inflammatory diseases.

Authors:  Yeo Joo Kim; Jina Youm; Jee Hyun Kim; Byung Chul Jee
Journal:  Obstet Gynecol Sci       Date:  2014-09-17

4.  Abdominal and pelvic actinomycosis due to longstanding intrauterine device: a slow and devastating infection.

Authors:  Evelyn Sue Nakahira; Linda Ferreira Maximiano; Fabiana Roberto Lima; Edson Yassushi Ussami
Journal:  Autops Case Rep       Date:  2017-03-30

5.  A Complicated Thread: Abdominal Actinomycosis in a Young Woman with Crohn Disease.

Authors:  Ari Nahum; Gregory Filice; Ashish Malhotra
Journal:  Case Rep Gastroenterol       Date:  2017-06-14

Review 6.  Pelvic Actinomycosis.

Authors:  Alejandra García-García; Ninfa Ramírez-Durán; Horacio Sandoval-Trujillo; María Del Socorro Romero-Figueroa
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-06-08       Impact factor: 2.471
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.